Acetaminophen / hydrocodone Alternatives Compared
Acetaminophen / hydrocodone | Tramadol | Gabapentin |
|
---|
Acetaminophen / hydrocodone | Tramadol | Gabapentin |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Acetaminophen/hydrocodone may be used to treat moderate-to-severe pain that is unrelieved by nonopioid analgesics. However, its use is limited by the dependence and addiction potential of the... View more |
Prescription only
Tramadol is a strong pain relief medicine effective for both general and nerve-related pain. Tramadol can cause dependence and use may be limited by side effects such as nausea and... View more |
Prescription only
Gabapentin may be used in the treatment of partial-onset seizures and nerve pain but is likely to cause dizziness or drowsiness. Gabapentin enacarbil (brand name Horizant), a prodrug of gabapentin... View more |
Related suggestions Back Pain
|
|||||||||||||||||||||||
More about Acetaminophen / hydrocodone | More about Tramadol | More about Gabapentin | ||||||||||||||||||||||||
Generic Status | ||||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Acetaminophen / hydrocodone has an average rating of 6.0 out of 10 from a total of 1330 ratings on Drugs.com. 51% of reviewers reported a positive effect, while 34% reported a negative effect. |
Tramadol has an average rating of 6.9 out of 10 from a total of 1833 ratings on Drugs.com. 61% of reviewers reported a positive effect, while 24% reported a negative effect. |
Gabapentin has an average rating of 7.1 out of 10 from a total of 2482 ratings on Drugs.com. 63% of reviewers reported a positive effect, while 21% reported a negative effect. |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Side Effects | ||||||||||||||||||||||||||
See also: acetaminophen / hydrocodone side effects in more detail. |
See also: tramadol side effects in more detail. |
See also: gabapentin side effects in more detail. |
||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all acetaminophen / hydrocodone prices |
View all tramadol prices |
View all gabapentin prices |
||||||||||||||||||||||||
Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
Xodol, Zyfrel | ConZip, Qdolo, Tramadol Hydrochloride ER | Fanatrex, Gabarone, Gralise, Neurontin | ||||||||||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
3.8 hours |
5.2 hours |
6 hours |
||||||||||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
High potential for abuse
Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. |
Some potential for abuse
Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 619 drugs are known to interact with acetaminophen / hydrocodone:
|
A total of 655 drugs are known to interact with tramadol:
|
A total of 266 drugs are known to interact with gabapentin:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
May 03, 1982 |
March 03, 1995 |
December 30, 1993 |
||||||||||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
|
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.